LivaNova PLC (LIVN)

Etorro trading 970x250
LivaNova PLC (LIVN) Logo

About LivaNova PLC

LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. It operates in two segments, Cardiovascular (CV) and Neuromodulation (NM). The CV segment develops, produces, and sells cardiopulmonary products, including heart-lung machines, oxygenators, perfusion tubing sets, cannulae, and accessories, as well as related equipment and disposables for autotransfusion and autologous blood washing for neonatal, pediatric, and adult patients. It also provides surgical tissue and mechanical valve replacements, and repair products for damaged or diseased heart valves, such as self-anchoring tissue heart, tissue heart, and mechanical heart valves, as well as heart valve repair products; and temporary extracorporeal cardiopulmonary life support solutions for critically ill patients. The NM segment designs, develops, and markets VNS Therapy System, an implantable device that delivers vagus nerve stimulation (VNS) therapy for the treatment of drug-resistant epilepsy, difficult-to-treat depression, and obstructive sleep apnea. It is also involved in the development and clinical testing of the VITARIA System for treating heart failure through VNS. The company serves perfusionists, neurologists, neurosurgeons, and other physicians, as well as hospitals, other medical institutions, and healthcare providers. It sells its products through direct sales representatives and independent distributors. The company has a research collaboration with Verily to capture clinical biomarkers of depression. LivaNova PLC was founded in 1987 and is headquartered in London, the United Kingdom. Address: 20 Eastbourne Terrace, London, United Kingdom, W2 6LG

LivaNova PLC News and around…

Latest news about LivaNova PLC (LIVN) common stock and company :

We Did The Math SPMD Can Go To $55
19 Oct, 2021 FinancialContent

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the SPDR— Portfolio S&P 400 Mid Cap ETF (SPMD), we found that the implied analyst target price for the ETF based upon its underlying holdings is $54.60 per unit.

Hedge Funds Have Never Been This Bullish On LivaNova PLC (LIVN)
12 Oct, 2021 Yahoo! Finance

In this article we will analyze whether LivaNova PLC (NASDAQ:LIVN) is a good investment right now by following the lead of some of the best investors in the world and piggybacking their ideas. There’s no better way to get these firms’ immense resources and analytical capabilities working for us than to follow their lead into […]

LivaNova (LIVN) Sees Hammer Chart Pattern: Time to Buy?
05 Oct, 2021 Yahoo! Finance

LivaNova (LIVN) has been struggling lately, but the selling pressure may be coming to an end soon.

LivaNova to Host Conference Call for Third Quarter 2021 Results
04 Oct, 2021 FinancialContent

LivaNova PLC will host a conference call to discuss its third quarter 2021 results on Wednesday, Nov. 3, 2021 at 12 p.m. London/8 a.m. Eastern time.

Are LivaNova PLC (NASDAQ:LIVN) Investors Paying Above The Intrinsic Value?
30 Sep, 2021 Yahoo! Finance

How far off is LivaNova PLC ( NASDAQ:LIVN ) from its intrinsic value? Using the most recent financial data, we'll take...

Analysts Predict 12% Upside For MVV
17 Sep, 2021 FinancialContent

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the ProShares Ultra MidCap400 ETF (MVV), we found that the implied analyst target price for the ETF based upon its underlying holdings is $71.92 per unit.

Helius Medical Technologies, Inc. Appoints Paul Buckman to its Board of Directors
14 Sep, 2021 FinancialContent
LivaNova to Present at the Baird 2021 Global Healthcare Conference
26 Aug, 2021 FinancialContent

LivaNova today announced CEO Damien McDonald will present at the Baird 2021 Global Healthcare Conference on Wednesday, September 15 at 9:40 a.m. ET.

10 Biggest Price Target Changes For Friday
20 Aug, 2021 FinancialContent

Raymond James boosted the price target on The Est Lauder Companies Inc. (NYSE: EL) from $355 to $375. Est Lauder ...

How The Pieces Add Up: EWMC Targets $103
17 Aug, 2021 FinancialContent

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the Invesco S&P MidCap 400— Equal Weight ETF (EWMC), we found that the implied analyst target price for the ETF based upon its underlying holdings is $103.29 per unit.

Livanova Meets 80-Plus Relative Strength Rating Benchmark
17 Aug, 2021 FinancialContent

Livanova shows rising price performance, earning an upgrade to its IBD Relative Strength Rating from 73 to 81.

LivaNova Announces Early Retirement of $450 Million Term Loan and Executes $125 Million Revolving Credit Facility
16 Aug, 2021 FinancialContent

LivaNova PLC today announced the early retirement of its $450 million five-year senior secured term loan.

Looking into LivaNova's Return on Capital Employed
04 Aug, 2021 FinancialContent

Pulled from Benzinga Pro data LivaNova (NASDAQ:LIVN) reported Q2 sales of $264.50 million. Earnings fell to a loss of $34.86 million, ...

LivaNova Prices Offering of Ordinary Shares
03 Aug, 2021 FinancialContent

LivaNova PLC announced that it has priced an underwritten offering of 3,636,364 ordinary shares at a price to the public of $82.50 per share.

LivaNova Announces Offering of Ordinary Shares
02 Aug, 2021 FinancialContent

LivaNova PLC (NASDAQ:LIVN) today announced it has commenced an underwritten offering of $300 million of its ordinary shares.

Interesting LIVN Put And Call Options For December 2022
30 Jul, 2021 FinancialContent

Investors in LivaNova PLC (LIVN) saw new options become available this week, for the December 2022 expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time value, so with 504 days until expiration the newly available contracts represent a possible opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration..

Livanova Hits 80-Plus Relative Strength Rating Benchmark
29 Jul, 2021 FinancialContent

Livanova shows rising price performance, earning an upgrade to its IBD Relative Strength Rating from 77 to 83.

LivaNova PLC (LIVN) Q2 2021 Earnings Call Transcript
28 Jul, 2021 FinancialContent

LIVN earnings call for the period ending June 30, 2021.

LivaNova (LIVN) Q2 Earnings and Revenues Top Estimates
28 Jul, 2021 Yahoo! Finance

LivaNova (LIVN) delivered earnings and revenue surprises of 62.50% and 9.42%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

LivaNova Reports Second Quarter 2021 Results and Appoints Alex Shvartsburg as Chief Financial Officer
28 Jul, 2021 FinancialContent

LivaNova PLC, a market-leading medical technology and innovation company, today reported results for the quarter ended June 30, 2021.

LivaNova's Earnings: A Preview
27 Jul, 2021 FinancialContent

LivaNova (NASDAQ:LIVN) will be releasing its next round of earnings this Wednesday, July 28. For all of the relevant information, here ...

What Does LivaNova's Debt Look Like?
26 Jul, 2021 FinancialContent

Shares of LivaNova (NASDAQ:LIVN) fell by 3.55% in the past three months. Before having a look at the importance of debt, let ...

Notable Wednesday Option Activity: LIVN, ASH, KRYS
21 Jul, 2021 FinancialContent

Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in LivaNova PLC (LIVN), where a total volume of 1,502 contracts has been traded thus far today, a contract volume which is representative of approximately 150,200 underlying shares (given that every 1 contract represents 100 underlying shares). That number works out to 66.3% of LIVN's average daily trading volume over the past month, of 226,510 shares..

LivaNova (LIVN) Reports Next Week: Wall Street Expects Earnings Growth
21 Jul, 2021 Yahoo! Finance

LivaNova (LIVN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Benzinga's Top Ratings Upgrades, Downgrades For July 20, 2021
20 Jul, 2021 FinancialContent

Upgrades For Bank of Marin Bancorp (NASDAQ:BMRC), Keefe, Bruyette & Woods upgraded the previous rating of Market ...

Analysts Anticipate MVV To Hit $69
14 Jul, 2021 FinancialContent

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the ProShares Ultra MidCap400 ETF (MVV), we found that the implied analyst target price for the ETF based upon its underlying holdings is $69.01 per unit.

Where Do Hedge Funds Stand On LivaNova PLC (LIVN)?
12 Jul, 2021 Yahoo! Finance

Is LivaNova PLC (NASDAQ:LIVN) a good place to invest some of your money right now? We can gain invaluable insight to help us answer that question by studying the investment trends of top investors, who employ world-class Ivy League graduates, who are given immense resources and industry contacts to put their financial expertise to work. […]

At US$85.27, Is LivaNova PLC (NASDAQ:LIVN) Worth Looking At Closely?
02 Jul, 2021 Yahoo! Finance

LivaNova PLC ( NASDAQ:LIVN ), is not the largest company out there, but it saw a double-digit share price rise of over...

LivaNova to Host Conference Call for Second Quarter 2021 Results
28 Jun, 2021 FinancialContent

LivaNova PLC will host a conference call to discuss its second quarter 2021 results on Wednesday, July 28, 2021 at 1 p.m. London time (8 a.m. EDT).

Livanova Clears Technical Benchmark, Hitting 80-Plus RS Rating
18 Jun, 2021 FinancialContent

A Relative Strength Rating upgrade for Livanova shows improving technical performance.

LivaNova PLC (LIVN) is a NASDAQ Common Stock listed in , ,

970x250